Opinion: Too many older Americans are getting tested for Alzheimer’s
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...
Yahoo Finance5d
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
RICHMOND, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...
TMCnet2d
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
RICHMOND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...
Business Insider6d
BioAge Labs to present preclinical data for azelaprag
BioAge Labs (BIOA) announced that it will present new preclinical data for its lead product candidate azelaprag, an orally available small molecule agonist of the apelin receptor APJ. The data ...
TMCnet5d
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
"Our preclinical data highlight the potential of azelaprag as a novel oral therapy for obesity," said Kristen Fortney, Ph.D., CEO and co-founder of BioAge. “Our two presentations provide evidence ...
Nature4d
Blood test could help diagnose bipolar disorder — but some researchers are sceptical
A first-of-its-kind blood test that uses biomarkers to distinguish bipolar disorder from depression could slash the time it ...
pharmaphorum2d
BioAge's $100m IPO, and other biotech financings
Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...